sang et organes humains – Souveraineté sanitaire : fabrication de médicaments dérivés du plasma

This written question concerns the national sovereignty of France in the production of medicines derived from human plasma. It addresses the importance of self-sufficiency in this critical area of healthcare. The question seeks to understand the government's strategy to ensure France's independence in manufacturing these vital medical products, impacting patients and the national health system.